Raffaele Ingenito

This inventor holds 13 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Ra Pharmaceuticals, Inc., Sanofi. Active years: 2011-2024.

USPTO Granted Patents = 13 (Patent Applications = 8)

% Patents Active = 92.3

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 4 (Patent Applications = 16)

Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Rome, IT (2011)
Pomezia, IT (2011 - 2024)

Company Filing History:

5 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 28

Ra Pharmaceuticals, Inc.

Instituto Di Ricerche Di Biologia Molecolare P. Angeletti

patents

5. 1 out of 1

Istituto De Ricerche Di Biologia Molecolare P. Angeletti Spa.

patent

6. 1 out of 4

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.r.l.

patents

7. 1 out of 431

Janssen Biotech, Inc.

patents

8. 1 out of 35

Protagonist Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12018057 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2024-06-25),

2. 12012468 - Cyclic polypeptides for PCSK9 inhibition (2024-06-18),

3. 11932705 - Cyclic polypeptides for PCSK9 inhibition (2024-03-19),

4. 11725036 - Modified lipidated relaxin B chain peptides and their therapeutic use (2023-08-15),

5. 11530244 - Cyclic polypeptides for PCSK9 inhibition (2022-12-20),

6. 11505575 - Cyclic polypeptides for PCSK9 inhibition (2022-11-22),

7. 11306125 - PCSK9 antagonists bicyclo-compounds (2022-04-19),

8. 10988524 - Modified relaxin B chain peptides and their therapeutic use (2021-04-27),

9. 10988523 - Modified lipidated Relaxin B chain peptides and their therapeutic use (2021-04-27),

10. 10961295 - Modified lipidated Relaxin B chain peptides and their therapeutic use (2021-03-30),

11. 8362030 - Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) (2013-01-29),

12. 8026265 - Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors (2011-09-27),

13. 7863294 - Heterocycle derivatives as histone deacetylase (HDAC) inhibitors (2011-01-04),

Title: The Innovative Mind of Raffaele Ingenito

Introduction:

Raffaele Ingenito, a talented inventor hailing from Pomezia, Italy, is renowned for his groundbreaking contributions to the field of innovation and technology.

Latest Patents:

Raffaele Ingenito holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights:

Throughout his illustrious career, Raffaele Ingenito has consistently pushed the boundaries of technological advancement, with his inventions revolutionizing industries and improving the lives of many.

Collaborations:

Raffaele Ingenito has collaborated with leading research institutions, universities, and innovative companies, fostering a culture of creativity and excellence in the pursuit of groundbreaking inventions.

Conclusion:

In conclusion, Raffaele Ingenito stands as a beacon of innovation, with his inventive spirit and dedication to progress leaving an indelible mark on the world of technology and beyond.